globeandmail.com
    globeandmail.com/globe-investor/portfolio-and-tools

Renaissance Glob Sci and Tech F USD
  Profiles Help     Click here to print this page

Fund Sponsor: CIBC Asset Management
Portfolio Manager:
Fund Type: Open-Ended

Asset Class: Global Equity
5-Star Rating:
RRSP Eligible: Yes

Inception Date: December, 2000
Total Assets: n/a
Sales Fee Type: No Load
Mgmt Expense Ratio (MER): 1.81%
Closed: No

Min. Invest (initial):
Subsequent:
Min. Invest (initial RRSP):
Subsequent RRSP:
Restricted: No


Statistics


As of January 18, 2018

Current Price: $7.62
Daily Change $: $0.02
1 day: 0.25%
7 day: 1.61%
Month-to-Date: 6.77%
30 day: 5.37%
Year-to-Date: 6.77%

Returns as of December 31, 2017
Fund Group Avg Index*
1 month -0.39% -0.62% -1.40%
3 month 6.86% 4.59% 5.81%
6 month 15.74% 6.02% 6.95%
1 year 41.72% 13.81% 14.99%
3 year 16.55% 8.77% 12.80%
5 year n/a 12.21% 17.54%
10 year n/a 5.09% 8.19%
15 year n/a 6.10% 7.78%
20 year n/a 4.82% 5.83%
Since Inception n/a n/a n/a
3 year risk 12.60 10.68 11.00
3 year beta 0.75 0.79 1.00
* Index refers to MSCI World TR CAD

Top Holdings as of Dec 29, 2017
Facebook Inc Ord       7.72%
Cad Cash       7.53%
Apple Computer       6.94%
Microsoft Corp Ord       6.51%
Amazon.Com Inc Ord       6.01%
Visa Inc Ord       5.06%
Tencent Holdings Ltd Ord       4.98%
Broadcom Ltd Ord       4.91%
Google Inc Cl A Ord       4.68%
Mastercard Inc Ord       4.42%
Extras

Fund Report
Review and compare the current price and performance of all CIBC Asset Management

Charting
Generate different performance charts for this Mutual Fund

PDF Fund Profile
Generate a full-color, print-ready profile in PDF format for this Mutual Fund

Fund Codes & Fees
View fund code, load type, trailer fee and fee schedule data for this Mutual Fund.

Fund Price History
View a 30-day price history for this fund


Investment Objectives
To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. We will not change the Funds fundamental investment objectives without the consent of unitholders by a majority of votes cast at a meeting of unitholders.

Portfolio Composition
as of Dec 29, 2017

Sector Weightings
as of Dec 29, 2017

Stock 91.95% Information Technology 75.89%
Cash and Short Term Securities 8.05% Health Care 10.04%
Consumer Discretionary 6.01%

Portfolio Manager(s)